Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
Rapid growth and unrestrained proliferation is a hallmark of many cancers. To accomplish this, cancer cells re-wire and increase their biosynthetic and metabolic activities, including ribosome biogenesis (RiBi), a complex, highly energy-consuming process. Several chemotherapeutic agents used in the...
Main Authors: | Asimina Zisi, Jiri Bartek, Mikael S. Lindström |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/9/2126 |
Similar Items
-
9-Aminoacridine Inhibits Ribosome Biogenesis by Targeting Both Transcription and Processing of Ribosomal RNA
by: Leonid Anikin, et al.
Published: (2022-01-01) -
Commuting to Work: Nucleolar Long Non-Coding RNA Control Ribosome Biogenesis from Near and Far
by: Victoria Mamontova, et al.
Published: (2021-07-01) -
p53 -Dependent and -Independent Nucleolar Stress Responses
by: Mikael S. Lindström, et al.
Published: (2012-10-01) -
Human RPF1 and ESF1 in Pre-rRNA Processing and the Assembly of Pre-Ribosomal Particles: A Functional Study
by: Alexander Deryabin, et al.
Published: (2024-02-01) -
The Ribosome Biogenesis—Cancer Connection
by: Marianna Penzo, et al.
Published: (2019-01-01)